首页 > 最新文献

The Journal of the Association of Physicians of India最新文献

英文 中文
Blue Index as a Comprehensive, Patient-centered Assessment of Care in Diabetic Patients. 蓝色指数作为以患者为中心的糖尿病患者综合护理评估。
Q3 Medicine Pub Date : 2024-10-01 DOI: 10.59556/japi.72.0688
Rupak Chatterjee, Arindam Naskar, Shambo Samrat Samajdar, Shatavisa Mukherjee, Shashank Joshi, Partha Sarathi Karmakar

Background: Assessment of diabetes health takes into account metabolic, nonmetabolic, and self-care measures like diet, exercise, follow-up, and habits. On the other hand, the index of complications includes the macro- and microvascular complications of diabetes along with foot complications. The Blue Index (BI) is a composite assessment of both diabetic health-related parameters and systemic complications stemming from diabetes. The present study aimed to evaluate the diabetes control status of the patients as a single index.

Methods: A prospective, observational study included a total of 100 adult diabetic patients in whom diabetic health status (DHS) and Komplications Score (KS) were assessed for cardiovascular/macrovascular, microvascular, and foot complications. The BI was calculated as a composite ratio, and measures were obtained at baseline, after 3 months, and at 6 months. Data were statistically analyzed.

Results: Diabetic health status significantly increased at the 3rd month and the 6th month, respectively, compared to baseline (p = 0.000). KS significantly decreased at the 3rd month and the 6th month, respectively, compared to baseline measures (p = 0.000). The composite BI scores showed a steady increase of 9.62 at the 3rd month and 13.14 at the 6th month, respectively, compared to baseline. Assessing based on the duration of diabetes detection, the scores of DHS, KS, and BI showed similar changes. Assessing based on patients' gender, DHS was significantly higher in females at baseline compared to males, with gradual improvement in scores over time for both genders. Contrastingly, KS was significantly lower in males compared to females, with scores showing gradual decrement over the time frame, signifying improvement in complications. DHS was significantly correlated with the duration of diabetes detection (p = 0.001) and age (p = 0.01).

Conclusion: The BI is a simple tool that incorporates various parameters covering different aspects of diabetes care, including complications. It may be used not only by endocrinologists but also by all physicians as a tool to monitor and improve diabetic care.

背景:糖尿病健康评估需要考虑代谢、非代谢以及饮食、运动、随访和习惯等自我保健措施。另一方面,并发症指数包括糖尿病的大血管和微血管并发症以及足部并发症。蓝色指数(BI)是对糖尿病健康相关参数和糖尿病全身并发症的综合评估。本研究旨在以单一指数评估患者的糖尿病控制状况:这项前瞻性观察研究共纳入了 100 名成年糖尿病患者,对他们的糖尿病健康状况(DHS)和并发症评分(KS)进行了评估,包括心血管/大血管并发症、微血管并发症和足部并发症。BI 以综合比率计算,分别在基线、3 个月后和 6 个月时测量。对数据进行了统计分析:结果:与基线相比,糖尿病患者的健康状况在第 3 个月和第 6 个月分别有明显改善(P = 0.000)。与基线相比,KS 分别在第 3 个月和第 6 个月明显下降(p = 0.000)。与基线相比,BI 综合得分在第 3 个月和第 6 个月分别稳步上升至 9.62 分和 13.14 分。根据发现糖尿病的时间长短进行评估,DHS、KS 和 BI 的得分显示出相似的变化。根据患者的性别进行评估,女性的 DHS 在基线时明显高于男性,随着时间的推移,男女患者的得分都在逐步提高。与此形成对比的是,男性的 KS 显著低于女性,随着时间的推移,得分逐渐降低,这表明并发症有所改善。DHS 与发现糖尿病的时间(p = 0.001)和年龄(p = 0.01)明显相关:BI 是一种简单的工具,它包含了糖尿病护理不同方面的各种参数,包括并发症。结论:BI 是一种简单的工具,包含了糖尿病护理不同方面(包括并发症)的各种参数,不仅可供内分泌科医生使用,也可供所有医生作为监测和改善糖尿病护理的工具。
{"title":"Blue Index as a Comprehensive, Patient-centered Assessment of Care in Diabetic Patients.","authors":"Rupak Chatterjee, Arindam Naskar, Shambo Samrat Samajdar, Shatavisa Mukherjee, Shashank Joshi, Partha Sarathi Karmakar","doi":"10.59556/japi.72.0688","DOIUrl":"10.59556/japi.72.0688","url":null,"abstract":"<p><strong>Background: </strong>Assessment of diabetes health takes into account metabolic, nonmetabolic, and self-care measures like diet, exercise, follow-up, and habits. On the other hand, the index of complications includes the macro- and microvascular complications of diabetes along with foot complications. The Blue Index (BI) is a composite assessment of both diabetic health-related parameters and systemic complications stemming from diabetes. The present study aimed to evaluate the diabetes control status of the patients as a single index.</p><p><strong>Methods: </strong>A prospective, observational study included a total of 100 adult diabetic patients in whom diabetic health status (DHS) and Komplications Score (KS) were assessed for cardiovascular/macrovascular, microvascular, and foot complications. The BI was calculated as a composite ratio, and measures were obtained at baseline, after 3 months, and at 6 months. Data were statistically analyzed.</p><p><strong>Results: </strong>Diabetic health status significantly increased at the 3rd month and the 6th month, respectively, compared to baseline (<i>p</i> = 0.000). KS significantly decreased at the 3rd month and the 6th month, respectively, compared to baseline measures (<i>p</i> = 0.000). The composite BI scores showed a steady increase of 9.62 at the 3rd month and 13.14 at the 6th month, respectively, compared to baseline. Assessing based on the duration of diabetes detection, the scores of DHS, KS, and BI showed similar changes. Assessing based on patients' gender, DHS was significantly higher in females at baseline compared to males, with gradual improvement in scores over time for both genders. Contrastingly, KS was significantly lower in males compared to females, with scores showing gradual decrement over the time frame, signifying improvement in complications. DHS was significantly correlated with the duration of diabetes detection (<i>p</i> = 0.001) and age (<i>p</i> = 0.01).</p><p><strong>Conclusion: </strong>The BI is a simple tool that incorporates various parameters covering different aspects of diabetes care, including complications. It may be used not only by endocrinologists but also by all physicians as a tool to monitor and improve diabetic care.</p>","PeriodicalId":22693,"journal":{"name":"The Journal of the Association of Physicians of India","volume":"72 10","pages":"e1-e5"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142401411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gluconephrotic Syndrome: A Comprehensive Review. 葡萄糖肾病综合征:全面回顾。
Q3 Medicine Pub Date : 2024-10-01 DOI: 10.59556/japi.72.0687
Sourabh Sharma, Sanjay Kalra

This article provides an overview of the diabetic kidney disease paradigm, explaining important aspects such as prognostic markers, clinical assessments, and therapeutic options. The importance of the term gluconephrotic syndrome (GlucoNS) is emphasized, highlighting its significant influence on clinical evaluations, research procedures, screening techniques, and patient care. This term encapsulates nephrotic syndrome (NS) within the diabetic milieu, shedding light on the intricate relationship between renal complications and diabetes. GlucoNS necessitates a refined approach, considering the unique challenges posed by diabetes in the context of NS. With this review, we want to highlight how important it is to assess diabetes in every case of NS and how important it is to assess albuminuria in every diabetic patient.

本文概述了糖尿病肾病模式,解释了预后指标、临床评估和治疗方案等重要方面。文章强调了葡萄糖肾病综合征(GlucoNS)这一术语的重要性,突出了它对临床评估、研究程序、筛查技术和患者护理的重要影响。该术语将肾病综合征(NS)囊括在糖尿病环境中,揭示了肾脏并发症与糖尿病之间错综复杂的关系。考虑到糖尿病给肾病综合征带来的独特挑战,葡萄糖性肾病综合征(GlucoNS)需要一种精细的方法。通过这篇综述,我们希望强调在每一个 NS 病例中评估糖尿病的重要性,以及在每一个糖尿病患者中评估白蛋白尿的重要性。
{"title":"Gluconephrotic Syndrome: A Comprehensive Review.","authors":"Sourabh Sharma, Sanjay Kalra","doi":"10.59556/japi.72.0687","DOIUrl":"https://doi.org/10.59556/japi.72.0687","url":null,"abstract":"<p><p>This article provides an overview of the diabetic kidney disease paradigm, explaining important aspects such as prognostic markers, clinical assessments, and therapeutic options. The importance of the term gluconephrotic syndrome (GlucoNS) is emphasized, highlighting its significant influence on clinical evaluations, research procedures, screening techniques, and patient care. This term encapsulates nephrotic syndrome (NS) within the diabetic milieu, shedding light on the intricate relationship between renal complications and diabetes. GlucoNS necessitates a refined approach, considering the unique challenges posed by diabetes in the context of NS. With this review, we want to highlight how important it is to assess diabetes in every case of NS and how important it is to assess albuminuria in every diabetic patient.</p>","PeriodicalId":22693,"journal":{"name":"The Journal of the Association of Physicians of India","volume":"72 10","pages":"58-62"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142401332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multilevel Vertebral Body Osteonecrosis in an Adult Patient: A Rare Case with Review of Literature. 一名成人患者的多层椎体骨坏死:一个罕见病例及文献综述
Q3 Medicine Pub Date : 2024-10-01 DOI: 10.59556/japi.72.0640
Sonal Saran, Akash Rauniyar, Bhumireddy Vijaya Madhuri, Pooja Kundu

Osteonecrosis, characterized by ischemic bone injury leading to cell death and bone resorption, manifests in various anatomical sites due to multiple etiologies such as radiotherapy and medications. While certain sites like the femoral head and jaw have garnered attention, vertebral body osteonecrosis remains less explored and lacks a standardized classification system. This report presents a unique case of a 52-year-old woman undergoing chemotherapy for diffuse large B-cell lymphoma who developed multilevel vertebral body osteonecrosis, a rare occurrence in English medical literature. The patient presented with fever, abdominal pain, and lymphoid malignancy markers, initiating chemotherapy with the rituximab, cyclophosphamide, vincristine, and prednisolone (R-CVP) regimen. During treatment, she experienced breathing difficulties and back pain, prompting imaging studies revealing extensive osteonecrosis affecting multiple vertebrae and other skeletal sites. Various factors, including chemotherapy, human immunodeficiency virus (HIV) therapy, trauma, and others, contribute to vertebral body necrosis. While osteonecrosis in lymphoma patients is rare, chemotherapy-induced marrow necrosis can lead to bone involvement. Vertebral bodies, especially their anterior portions, are susceptible due to limited blood supply. The presence of an intravertebral vacuum cleft on radiographs is pathognomonic for osteonecrosis, while magnetic resonance imaging (MRI) reveals hypointense areas and fluid collections. This case underscores the complexity of diagnosing and managing multilevel vertebral body osteonecrosis, exacerbated by the lack of standardized protocols. The interplay between disease processes and treatment modalities complicates decision-making, emphasizing the need for further research to establish optimal diagnostic and treatment guidelines. In conclusion, this case sheds light on a rare manifestation of osteonecrosis in a lymphoma patient, highlighting the challenges in diagnosis and management. Further research is warranted to enhance understanding and improve outcomes for patients with this debilitating condition.

骨坏死的特点是缺血性骨损伤导致细胞死亡和骨吸收,由于放疗和药物等多种病因,骨坏死表现在不同的解剖部位。股骨头和颌骨等某些部位的骨坏死已引起人们的关注,但椎体骨坏死的研究仍较少,也缺乏标准化的分类系统。本报告介绍了一例独特的病例,一名52岁的女性患者因弥漫大B细胞淋巴瘤接受化疗,出现多发性椎体骨坏死,这在英文医学文献中十分罕见。患者出现发热、腹痛和淋巴恶性肿瘤标志物,开始接受利妥昔单抗、环磷酰胺、长春新碱和泼尼松龙(R-CVP)方案化疗。治疗期间,她出现了呼吸困难和背痛,影像学检查显示她的多节椎骨和其他骨骼部位出现了广泛的骨坏死。化疗、人类免疫缺陷病毒(HIV)治疗、创伤等各种因素都会导致椎体坏死。虽然淋巴瘤患者骨坏死的情况很少见,但化疗引起的骨髓坏死可导致骨骼受累。由于血液供应有限,椎体,尤其是椎体前部,很容易受到影响。X线片上出现椎体内真空裂隙是骨坏死的先兆,而磁共振成像(MRI)可显示低密度区和积液。本病例强调了诊断和处理多级椎体骨坏死的复杂性,而标准化方案的缺乏又加剧了这一复杂性。疾病过程和治疗方式之间的相互作用使决策变得更加复杂,强调了进一步研究制定最佳诊断和治疗指南的必要性。总之,本病例揭示了淋巴瘤患者骨坏死的一种罕见表现,强调了诊断和管理方面的挑战。有必要开展进一步的研究,以加深对这一使人衰弱的疾病的理解并改善患者的预后。
{"title":"Multilevel Vertebral Body Osteonecrosis in an Adult Patient: A Rare Case with Review of Literature.","authors":"Sonal Saran, Akash Rauniyar, Bhumireddy Vijaya Madhuri, Pooja Kundu","doi":"10.59556/japi.72.0640","DOIUrl":"10.59556/japi.72.0640","url":null,"abstract":"<p><p>Osteonecrosis, characterized by ischemic bone injury leading to cell death and bone resorption, manifests in various anatomical sites due to multiple etiologies such as radiotherapy and medications. While certain sites like the femoral head and jaw have garnered attention, vertebral body osteonecrosis remains less explored and lacks a standardized classification system. This report presents a unique case of a 52-year-old woman undergoing chemotherapy for diffuse large B-cell lymphoma who developed multilevel vertebral body osteonecrosis, a rare occurrence in English medical literature. The patient presented with fever, abdominal pain, and lymphoid malignancy markers, initiating chemotherapy with the rituximab, cyclophosphamide, vincristine, and prednisolone (R-CVP) regimen. During treatment, she experienced breathing difficulties and back pain, prompting imaging studies revealing extensive osteonecrosis affecting multiple vertebrae and other skeletal sites. Various factors, including chemotherapy, human immunodeficiency virus (HIV) therapy, trauma, and others, contribute to vertebral body necrosis. While osteonecrosis in lymphoma patients is rare, chemotherapy-induced marrow necrosis can lead to bone involvement. Vertebral bodies, especially their anterior portions, are susceptible due to limited blood supply. The presence of an intravertebral vacuum cleft on radiographs is pathognomonic for osteonecrosis, while magnetic resonance imaging (MRI) reveals hypointense areas and fluid collections. This case underscores the complexity of diagnosing and managing multilevel vertebral body osteonecrosis, exacerbated by the lack of standardized protocols. The interplay between disease processes and treatment modalities complicates decision-making, emphasizing the need for further research to establish optimal diagnostic and treatment guidelines. In conclusion, this case sheds light on a rare manifestation of osteonecrosis in a lymphoma patient, highlighting the challenges in diagnosis and management. Further research is warranted to enhance understanding and improve outcomes for patients with this debilitating condition.</p>","PeriodicalId":22693,"journal":{"name":"The Journal of the Association of Physicians of India","volume":"72 10","pages":"96-98"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142401339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Late Postpartum Eclampsia with "Normal" Blood Pressure. 产后子痫晚期血压 "正常"。
Q3 Medicine Pub Date : 2024-10-01 DOI: 10.59556/japi.72.0661
Somarajan Anandan, Sajeesh S Rajendran, Jyothish P Kumar, Divine S Shajee

Majority of the eclampsia or preeclampsia occur between 20 weeks of gestation and within 48 hours postpartum. Postpartum eclampsia usually occurs on a background of preeclampsia. Late postpartum eclampsia (LPE) without preeclampsia is a rarity. LPE with posterior reversible encephalopathy syndrome (PRES) and mild hypertension is extremely rare. We report a case of LPE with PRES without preeclampsia, at a blood pressure of 140/90 mm Hg. Seizures occurring late postpartum period could be due to LPE and this can occur even with mild hypertension.

大多数子痫或子痫前期发生在妊娠 20 周至产后 48 小时内。产后子痫通常是在子痫前期的背景下发生的。没有子痫前期的晚期产后子痫(LPE)非常罕见。伴有后可逆性脑病综合征(PRES)和轻度高血压的 LPE 则极为罕见。我们报告了一例在血压为 140/90 mm Hg 时伴有后可逆性脑病综合征(PRES)但无子痫前期的 LPE。产后晚期出现的癫痫发作可能是 LPE 引起的,即使有轻度高血压也可能发生。
{"title":"Late Postpartum Eclampsia with \"Normal\" Blood Pressure.","authors":"Somarajan Anandan, Sajeesh S Rajendran, Jyothish P Kumar, Divine S Shajee","doi":"10.59556/japi.72.0661","DOIUrl":"10.59556/japi.72.0661","url":null,"abstract":"<p><p>Majority of the eclampsia or preeclampsia occur between 20 weeks of gestation and within 48 hours postpartum. Postpartum eclampsia usually occurs on a background of preeclampsia. Late postpartum eclampsia (LPE) without preeclampsia is a rarity. LPE with posterior reversible encephalopathy syndrome (PRES) and mild hypertension is extremely rare. We report a case of LPE with PRES without preeclampsia, at a blood pressure of 140/90 mm Hg. Seizures occurring late postpartum period could be due to LPE and this can occur even with mild hypertension.</p>","PeriodicalId":22693,"journal":{"name":"The Journal of the Association of Physicians of India","volume":"72 10","pages":"e37-e38"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142401337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Uncommon Finding of Plasma Cell Invasion of the Kidney in a Patient with Plasma Cell Dyscrasia: Should It be Considered a Myeloma Defining Event? 浆细胞增生异常患者肾脏出现浆细胞侵犯的罕见发现:是否应将其视为骨髓瘤定义事件?
Q3 Medicine Pub Date : 2024-10-01 DOI: 10.59556/japi.72.0708
Prem Shankar Patel, Archana, Om Kumar

Plasma cell invasion of the kidney in plasma cell dyscrasia is rare. We are reporting a case of plasma cell infiltration in the kidney presenting as rapidly progressing renal failure. The patient presented with generalized weakness, anemia, and advanced renal failure. The kidney biopsy revealed multifocal atypical CD138-positive plasma cell-rich interstitial inflammation and severe acute tubular injury. In the present situation of clinically unexplained renal failure with suspicion of plasma cell dyscrasia, a kidney biopsy proved to be key to the diagnosis. Hence, malignant plasma cell infiltration in the kidney could indicate underlying plasma cell dyscrasia and may serve as a future myeloma defining event (MDE).

浆细胞障碍性疾病中浆细胞侵犯肾脏的情况非常罕见。我们报告了一例浆细胞浸润肾脏并迅速发展为肾衰竭的病例。患者表现为全身乏力、贫血和晚期肾衰竭。肾脏活组织检查发现多灶性非典型 CD138 阳性富含浆细胞的间质炎症和严重的急性肾小管损伤。在目前这种临床原因不明的肾衰竭并怀疑浆细胞异常的情况下,肾活检被证明是诊断的关键。因此,肾脏中的恶性浆细胞浸润可能预示着潜在的浆细胞异常,并可能成为未来骨髓瘤的定义事件(MDE)。
{"title":"An Uncommon Finding of Plasma Cell Invasion of the Kidney in a Patient with Plasma Cell Dyscrasia: Should It be Considered a Myeloma Defining Event?","authors":"Prem Shankar Patel, Archana, Om Kumar","doi":"10.59556/japi.72.0708","DOIUrl":"10.59556/japi.72.0708","url":null,"abstract":"<p><p>Plasma cell invasion of the kidney in plasma cell dyscrasia is rare. We are reporting a case of plasma cell infiltration in the kidney presenting as rapidly progressing renal failure. The patient presented with generalized weakness, anemia, and advanced renal failure. The kidney biopsy revealed multifocal atypical CD138-positive plasma cell-rich interstitial inflammation and severe acute tubular injury. In the present situation of clinically unexplained renal failure with suspicion of plasma cell dyscrasia, a kidney biopsy proved to be key to the diagnosis. Hence, malignant plasma cell infiltration in the kidney could indicate underlying plasma cell dyscrasia and may serve as a future myeloma defining event (MDE).</p>","PeriodicalId":22693,"journal":{"name":"The Journal of the Association of Physicians of India","volume":"72 10","pages":"e28-e30"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142401409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does Adopting Western Low-density Lipoprotein Cholesterol Targets Expose Indians to a Higher Risk of Cardiovascular Events? Expert Opinion From the Lipid Association of India. 采用西方的低密度脂蛋白胆固醇目标是否会使印度人面临更高的心血管事件风险?印度血脂协会的专家意见。
Q3 Medicine Pub Date : 2024-10-01 DOI: 10.59556/japi.72.0692
Raman Puri, Vimal Mehta, Manish Bansal, P Barton Duell, S S Iyengar, Sadanand Shetty, Ian Graham, J C Mohan, Upendra Kaul, Dayasagar Rao, Rajeev Agarwala, Gurpreet Singh Wander, Prakash Hazra, Soumitra Kumar, S K Wangnoo, Abdul Hamid Zargar, Banshi Saboo, Jamal Yusuf, Vinod M Vijan, Prem Aggarwal, Sarat Chandra, Ravi R Kasliwal, P C Manoria, M U Rabbani, Milan C Chag, D Prabhakar, Aziz Khan, Neil Bordoloi, Saravanan Palanippan, Kunal Mahajan, Akshay Pradhan, Dharmender Jain, A Murugnathan, Pradeep Kumar Dabla, Nagaraj Desai, Mangesh H Tiwaskar, Devaki R Nair, Charanjeet Singh, Jayant Panda, Vitull Gupta, Prashant Sahoo, Nathan D Wong
<p><p>Adverse cardiovascular (CV) events have declined in Western countries due at least in part to aggressive risk factor control, including dyslipidemia management. The American and European (Western) dyslipidemia treatment guidelines have contributed significantly to the reduction in atherosclerotic cardiovascular disease (ASCVD) incidence in the respective populations. However, their direct extrapolation to Indian patients does not seem appropriate for the reasons described below. In the US, mean low-density lipoprotein cholesterol (LDL-C) levels have markedly declined over the last 2 decades, correlating with a proportional reduction in CV events. Conversely, poor risk factor control and dyslipidemia management have led to increased CV and coronary artery disease (CAD) mortality rates in India. The population-attributable risk of dyslipidemia is about 50% for myocardial infarction, signifying its major role in CV events. In addition, the pattern of dyslipidemia in Indians differs considerably from that in Western populations, requiring unique strategies for lipid management in Indians and modified treatment targets. The Lipid Association of India (LAI) recognized the need for tailored LDL-C targets for Indians and recommended lower targets compared to Western guidelines. For individuals with established ASCVD or diabetes with additional risk factors, an LDL-C target of <50 mg/dL was recommended, with an optional target of ≤30 mg/dL for individuals at extremely high risk. There are several reasons that necessitate these lower targets. In Indian subjects, CAD develops 10 years earlier than in Western populations and is more malignant. Additionally, Indians experience higher CAD mortality despite having lower basal LDL-C levels, requiring greater LDL-C reduction to achieve a comparable CV event reduction. The Indian Council for Medical Research-India Diabetes study described a high prevalence of dyslipidemia among Indians, characterized by relatively lower LDL-C levels, higher triglyceride levels, and lower high-density lipoprotein cholesterol (HDL-C) levels compared to Western populations. About 30% of Indians have hypertriglyceridemia, aggravating ASCVD risk and complicating dyslipidemia management. The levels of atherogenic triglyceride-rich lipoproteins, including remnant lipoproteins, are increased in hypertriglyceridemia and are predictive of CV events. Hypertriglyceridemia is also associated with higher levels of small, dense LDL particles, which are more atherogenic, and higher levels of apolipoprotein B (Apo B), reflecting a higher burden of circulating atherogenic lipoprotein particles. A high prevalence of low HDL-C, which is often dysfunctional, and elevated lipoprotein(a) [Lp(a)] levels further contribute to the heightened atherogenicity and premature CAD in Indians. Considering the unique characteristics of atherogenic dyslipidemia in Indians, lower LDL-C, non-HDL-C, and Apo B goals compared to Western guidelines are required for
在西方国家,不良心血管(CV)事件的减少至少部分归功于积极的风险因素控制,包括血脂异常管理。美国和欧洲(西方)的血脂异常治疗指南为降低各自人群的动脉粥样硬化性心血管疾病(ASCVD)发病率做出了重大贡献。然而,由于以下原因,将其直接推用于印度患者似乎并不合适。在美国,低密度脂蛋白胆固醇(LDL-C)的平均水平在过去 20 年中显著下降,这与心血管事件的减少成正比。相反,在印度,危险因素控制和血脂异常管理不力导致了心血管疾病和冠状动脉疾病(CAD)死亡率的上升。在心肌梗死中,血脂异常的人群归因风险约为 50%,这表明血脂异常在心血管事件中扮演着重要角色。此外,印度人的血脂异常模式与西方人群有很大不同,因此需要对印度人的血脂管理采取独特的策略,并对治疗目标进行调整。印度血脂协会(LAI)认识到需要为印度人量身定制低密度脂蛋白胆固醇目标,并推荐了比西方指南更低的目标。对于已有 ASCVD 或糖尿病并伴有其他风险因素的患者,低密度脂蛋白胆固醇目标值为
{"title":"Does Adopting Western Low-density Lipoprotein Cholesterol Targets Expose Indians to a Higher Risk of Cardiovascular Events? Expert Opinion From the Lipid Association of India.","authors":"Raman Puri, Vimal Mehta, Manish Bansal, P Barton Duell, S S Iyengar, Sadanand Shetty, Ian Graham, J C Mohan, Upendra Kaul, Dayasagar Rao, Rajeev Agarwala, Gurpreet Singh Wander, Prakash Hazra, Soumitra Kumar, S K Wangnoo, Abdul Hamid Zargar, Banshi Saboo, Jamal Yusuf, Vinod M Vijan, Prem Aggarwal, Sarat Chandra, Ravi R Kasliwal, P C Manoria, M U Rabbani, Milan C Chag, D Prabhakar, Aziz Khan, Neil Bordoloi, Saravanan Palanippan, Kunal Mahajan, Akshay Pradhan, Dharmender Jain, A Murugnathan, Pradeep Kumar Dabla, Nagaraj Desai, Mangesh H Tiwaskar, Devaki R Nair, Charanjeet Singh, Jayant Panda, Vitull Gupta, Prashant Sahoo, Nathan D Wong","doi":"10.59556/japi.72.0692","DOIUrl":"https://doi.org/10.59556/japi.72.0692","url":null,"abstract":"&lt;p&gt;&lt;p&gt;Adverse cardiovascular (CV) events have declined in Western countries due at least in part to aggressive risk factor control, including dyslipidemia management. The American and European (Western) dyslipidemia treatment guidelines have contributed significantly to the reduction in atherosclerotic cardiovascular disease (ASCVD) incidence in the respective populations. However, their direct extrapolation to Indian patients does not seem appropriate for the reasons described below. In the US, mean low-density lipoprotein cholesterol (LDL-C) levels have markedly declined over the last 2 decades, correlating with a proportional reduction in CV events. Conversely, poor risk factor control and dyslipidemia management have led to increased CV and coronary artery disease (CAD) mortality rates in India. The population-attributable risk of dyslipidemia is about 50% for myocardial infarction, signifying its major role in CV events. In addition, the pattern of dyslipidemia in Indians differs considerably from that in Western populations, requiring unique strategies for lipid management in Indians and modified treatment targets. The Lipid Association of India (LAI) recognized the need for tailored LDL-C targets for Indians and recommended lower targets compared to Western guidelines. For individuals with established ASCVD or diabetes with additional risk factors, an LDL-C target of &lt;50 mg/dL was recommended, with an optional target of ≤30 mg/dL for individuals at extremely high risk. There are several reasons that necessitate these lower targets. In Indian subjects, CAD develops 10 years earlier than in Western populations and is more malignant. Additionally, Indians experience higher CAD mortality despite having lower basal LDL-C levels, requiring greater LDL-C reduction to achieve a comparable CV event reduction. The Indian Council for Medical Research-India Diabetes study described a high prevalence of dyslipidemia among Indians, characterized by relatively lower LDL-C levels, higher triglyceride levels, and lower high-density lipoprotein cholesterol (HDL-C) levels compared to Western populations. About 30% of Indians have hypertriglyceridemia, aggravating ASCVD risk and complicating dyslipidemia management. The levels of atherogenic triglyceride-rich lipoproteins, including remnant lipoproteins, are increased in hypertriglyceridemia and are predictive of CV events. Hypertriglyceridemia is also associated with higher levels of small, dense LDL particles, which are more atherogenic, and higher levels of apolipoprotein B (Apo B), reflecting a higher burden of circulating atherogenic lipoprotein particles. A high prevalence of low HDL-C, which is often dysfunctional, and elevated lipoprotein(a) [Lp(a)] levels further contribute to the heightened atherogenicity and premature CAD in Indians. Considering the unique characteristics of atherogenic dyslipidemia in Indians, lower LDL-C, non-HDL-C, and Apo B goals compared to Western guidelines are required for ","PeriodicalId":22693,"journal":{"name":"The Journal of the Association of Physicians of India","volume":"72 10","pages":"71-76"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142401330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utility of Sonoelastography and Magnetic Resonance Imaging in Characterization of Thyroid Nodules. 超声弹性成像和磁共振成像在甲状腺结节特征描述中的应用
Q3 Medicine Pub Date : 2024-10-01 DOI: 10.59556/japi.72.0709
Upinderjeet Singh, Rekha Gupta, Ashok K Attri, Nitin Gupta, Uma Handa

Aim: To evaluate thyroid nodules with sonoelastography and magnetic resonance imaging (MRI).

Materials and methods: The study included 28 patients with 40 thyroid nodules. Clearance was obtained from the institute's ethical clearance committee. Patients with pure cystic nodules or nodules with eggshell calcification, diffuse thyroid pathology (such as Graves' disease, Hashimoto's thyroiditis, De Quervain thyroiditis, and Riedel's thyroiditis), inaccessible nodules via fine needle aspiration cytology (FNAC), or patients with a history of thyroid gland surgery were excluded from the study. Strain elastography was performed on a Phillips iU22 machine, producing qualitative color-coded strain maps (graded using the Rago 5-point system) and semiquantitative strain ratios. MRI was performed on a Phillips ACHIEVA 1.5T magnet with a head and neck coil.

Results: Rago scores statistically correlated (χ2 = 18.052, p < 0.001) with malignant nodules, and using the receiver operating characteristic (ROC) curve, the area under the ROC curve (AUROC) for the mean strain ratio predicting malignant outcomes was 0.88 [95% confidence interval (CI): 0.767-0.992], which was also statistically significant (p < 0.001). A cutoff of mean strain ratio ≥2.48 predicted malignant outcomes with 100% specificity. T2 signal intensity ratio (SIR) and apparent diffusion coefficient (ADC) values were not statistically significant in predicting malignant outcomes. Kinetic curves were statistically significant for Rago scores (χ2 = 11.356, p = 0.045); however, no significant difference was found in predicting malignant outcomes.

Conclusion and clinical significance: We concluded that sonoelastography, along with grayscale ultrasound, is a useful noninvasive technique for predicting histological outcomes. However, MRI should largely be reserved as a problem-solving tool rather than a standalone imaging modality. The kinetic curves show some degree of overlap between histologically distinct diseases, and thus large-scale multicenter trials are needed for further standardization.

目的:通过超声弹性成像和磁共振成像(MRI)评估甲状腺结节:研究包括 28 名患者,共 40 个甲状腺结节。研究获得了研究所伦理审查委员会的批准。纯囊性结节或伴有蛋壳钙化的结节、甲状腺弥漫性病变(如巴塞杜氏病、桥本氏甲状腺炎、德克尔曼甲状腺炎和里德尔甲状腺炎)、无法通过细针穿刺细胞学检查(FNAC)获得结节或有甲状腺手术史的患者均不在研究范围内。应变弹性成像是在菲利普斯 iU22 机器上进行的,可生成彩色编码的定性应变图(使用拉戈五点系统分级)和半定量应变比。核磁共振成像在带有头颈线圈的菲利普斯 ACHIEVA 1.5T 磁体上进行:Rago评分与恶性结节具有统计学相关性(χ2 = 18.052,P < 0.001),使用接收器操作特征曲线(ROC),预测恶性结果的平均应变比的ROC曲线下面积(AUROC)为0.88 [95%置信区间(CI):0.767-0.992],也具有统计学意义(P < 0.001)。平均应变比≥2.48的临界值可预测恶性结果,特异性为100%。T2 信号强度比(SIR)和表观弥散系数(ADC)值在预测恶性结果方面无统计学意义。动力学曲线对 Rago 评分有统计学意义(χ2 = 11.356,p = 0.045);但在预测恶性结果方面没有发现显著差异:我们的结论是,声弹性成像和灰度超声是预测组织学结果的一种有用的无创技术。然而,核磁共振成像应主要作为解决问题的工具,而不是独立的成像模式。动力学曲线显示不同组织学疾病之间存在一定程度的重叠,因此需要进行大规模的多中心试验以进一步标准化。
{"title":"Utility of Sonoelastography and Magnetic Resonance Imaging in Characterization of Thyroid Nodules.","authors":"Upinderjeet Singh, Rekha Gupta, Ashok K Attri, Nitin Gupta, Uma Handa","doi":"10.59556/japi.72.0709","DOIUrl":"https://doi.org/10.59556/japi.72.0709","url":null,"abstract":"<p><strong>Aim: </strong>To evaluate thyroid nodules with sonoelastography and magnetic resonance imaging (MRI).</p><p><strong>Materials and methods: </strong>The study included 28 patients with 40 thyroid nodules. Clearance was obtained from the institute's ethical clearance committee. Patients with pure cystic nodules or nodules with eggshell calcification, diffuse thyroid pathology (such as Graves' disease, Hashimoto's thyroiditis, De Quervain thyroiditis, and Riedel's thyroiditis), inaccessible nodules <i>via</i> fine needle aspiration cytology (FNAC), or patients with a history of thyroid gland surgery were excluded from the study. Strain elastography was performed on a Phillips iU22 machine, producing qualitative color-coded strain maps (graded using the Rago 5-point system) and semiquantitative strain ratios. MRI was performed on a Phillips ACHIEVA 1.5T magnet with a head and neck coil.</p><p><strong>Results: </strong>Rago scores statistically correlated (<i>χ</i><sup>2</sup> = 18.052, <i>p</i> < 0.001) with malignant nodules, and using the receiver operating characteristic (ROC) curve, the area under the ROC curve (AUROC) for the mean strain ratio predicting malignant outcomes was 0.88 [95% confidence interval (CI): 0.767-0.992], which was also statistically significant (<i>p</i> < 0.001). A cutoff of mean strain ratio ≥2.48 predicted malignant outcomes with 100% specificity. T2 signal intensity ratio (SIR) and apparent diffusion coefficient (ADC) values were not statistically significant in predicting malignant outcomes. Kinetic curves were statistically significant for Rago scores (<i>χ</i><sup>2</sup> = 11.356, <i>p</i> = 0.045); however, no significant difference was found in predicting malignant outcomes.</p><p><strong>Conclusion and clinical significance: </strong>We concluded that sonoelastography, along with grayscale ultrasound, is a useful noninvasive technique for predicting histological outcomes. However, MRI should largely be reserved as a problem-solving tool rather than a standalone imaging modality. The kinetic curves show some degree of overlap between histologically distinct diseases, and thus large-scale multicenter trials are needed for further standardization.</p>","PeriodicalId":22693,"journal":{"name":"The Journal of the Association of Physicians of India","volume":"72 10","pages":"e13-e17"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142401360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brudziński and His Signs. 布鲁津斯基和他的标志
Q3 Medicine Pub Date : 2024-10-01 DOI: 10.59556/japi.72.0697
Jayant Pai-Dhungat, Aparna Verma

Many among us and some students have a personal idiosyncrasy to remember eponyms in clinical medicine and other subjects such as signs, tests, phenomena, and rules named after a person who originally described them. However, it is not always necessary as long as one knows what they mean. Józef Brudziński's name is given to four eponymous medical signs associated with reflexes observed in meningeal irritation along with Kernig's sign.

在临床医学和其他学科中,我们中的许多人和一些学生都有记住外来语地名的个人怪癖,例如以最初描述它们的人的名字命名的标志、测试、现象和规则。不过,只要知道它们的含义,并不一定需要这样做。约瑟夫-布鲁钦斯基(Józef Brudziński)的名字被赋予了四个同名医学体征,这些体征与克尔尼格体征以及脑膜刺激时观察到的反射有关。
{"title":"Brudziński and His Signs.","authors":"Jayant Pai-Dhungat, Aparna Verma","doi":"10.59556/japi.72.0697","DOIUrl":"https://doi.org/10.59556/japi.72.0697","url":null,"abstract":"<p><p>Many among us and some students have a personal idiosyncrasy to remember eponyms in clinical medicine and other subjects such as signs, tests, phenomena, and rules named after a person who originally described them. However, it is not always necessary as long as one knows what they mean. Józef Brudziński's name is given to four eponymous medical signs associated with reflexes observed in meningeal irritation along with Kernig's sign.</p>","PeriodicalId":22693,"journal":{"name":"The Journal of the Association of Physicians of India","volume":"72 10","pages":"108"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142401413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimizing Traumatic Brain Injury Recovery: Exploring the Advantages and Results of Decompressive Craniectomy. 优化创伤性脑损伤的恢复:探索减压颅骨切除术的优势和效果。
Q3 Medicine Pub Date : 2024-10-01 DOI: 10.59556/japi.72.0705
Aryan Rafieezadeh, Kartik Prabhakaran, Amirhossein Sadeghian, Anna Mary Jose, Bardiya Zangbar

Traumatic brain injury (TBI) causes significant mortality and morbidity across regions, imposing a substantial socioeconomic burden on societies. A major complication that can arise is uncontrolled intracranial pressure (ICP). Several strategies exist for reducing ICP in TBI patients, including head elevation, mannitol administration, and hyperventilation. Decompressive craniectomy (DC) is a therapeutic approach employed to lower ICP. This technique offers immediate and permanent relief from elevated ICP, although there are ongoing debates regarding its beneficial use and appropriate indications for patients with increased ICP. The objective of this review was to assess variations in surgical technique, timing of the procedure, and patient characteristics associated with DC. Through the evaluation of clinical and radiologic data concerning DC in patients with elevated ICP, it was revealed that while DC provides numerous benefits, it also carries a significant risk of mortality and morbidity. Furthermore, we observed that factors such as age, initial Glasgow Coma Scale (GCS) score, pupil response, and the time interval between injury and DC can serve as predictors for the procedure's outcomes. Based on our findings, we recommend conducting further trials to shed light on the use of DC in TBI patients.

创伤性脑损伤(TBI)在各个地区都会造成严重的死亡率和发病率,给社会造成巨大的社会经济负担。可能出现的一个主要并发症是颅内压(ICP)失控。有几种策略可以降低创伤性脑损伤患者的 ICP,包括抬高头部、给予甘露醇和过度通气。减压开颅术(DC)是一种用于降低 ICP 的治疗方法。该技术可立即、永久地缓解 ICP 升高,但关于其对 ICP 增高患者的有益用途和适当适应症仍存在争议。本综述旨在评估与 DC 相关的手术技术、手术时机和患者特征的变化。通过评估有关 ICP 增高患者 DC 的临床和放射学数据,我们发现,虽然 DC 有诸多益处,但也有很大的死亡率和发病率风险。此外,我们还观察到,年龄、初始格拉斯哥昏迷量表(GCS)评分、瞳孔反应以及损伤与 DC 之间的时间间隔等因素可作为手术结果的预测因素。基于我们的研究结果,我们建议开展进一步的试验,以阐明如何在创伤性脑损伤患者中使用 DC。
{"title":"Optimizing Traumatic Brain Injury Recovery: Exploring the Advantages and Results of Decompressive Craniectomy.","authors":"Aryan Rafieezadeh, Kartik Prabhakaran, Amirhossein Sadeghian, Anna Mary Jose, Bardiya Zangbar","doi":"10.59556/japi.72.0705","DOIUrl":"https://doi.org/10.59556/japi.72.0705","url":null,"abstract":"<p><p>Traumatic brain injury (TBI) causes significant mortality and morbidity across regions, imposing a substantial socioeconomic burden on societies. A major complication that can arise is uncontrolled intracranial pressure (ICP). Several strategies exist for reducing ICP in TBI patients, including head elevation, mannitol administration, and hyperventilation. Decompressive craniectomy (DC) is a therapeutic approach employed to lower ICP. This technique offers immediate and permanent relief from elevated ICP, although there are ongoing debates regarding its beneficial use and appropriate indications for patients with increased ICP. The objective of this review was to assess variations in surgical technique, timing of the procedure, and patient characteristics associated with DC. Through the evaluation of clinical and radiologic data concerning DC in patients with elevated ICP, it was revealed that while DC provides numerous benefits, it also carries a significant risk of mortality and morbidity. Furthermore, we observed that factors such as age, initial Glasgow Coma Scale (GCS) score, pupil response, and the time interval between injury and DC can serve as predictors for the procedure's outcomes. Based on our findings, we recommend conducting further trials to shed light on the use of DC in TBI patients.</p>","PeriodicalId":22693,"journal":{"name":"The Journal of the Association of Physicians of India","volume":"72 10","pages":"e18-e22"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142401351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case of Streptococcus iniae Pyocephalus, Subdural Empyema, and Diffuse Leptomeningitis in an Elderly Male: A Case Report. 一例男性老人患有猪链球菌脑积水、硬膜下气肿和弥漫性盗汗症的病例:病例报告。
Q3 Medicine Pub Date : 2024-10-01 DOI: 10.59556/japi.72.0689
Abdeali Ginwala, Ajit Tambolkar, Sanjay Pujari

We present a case of Streptococcus iniae causing leptomeningitis, pyocephalus, and subdural empyema in an elderly male from India. There have been only a handful of cases of S. iniae infection reported worldwide, and none of them have been from India. In this case, an elderly diabetic patient presenting with backache, headache, and fever with severe neurological worsening was diagnosed with severe invasive S. iniae infection. He had hydrocephalus that needed ventriculoperitoneal shunting. The patient was treated with a prolonged course of intravenous ampicillin and vancomycin.

我们报告了一例印度老年男性因感染猪链球菌而导致脑脊髓膜炎、脑积水和硬膜下积水的病例。全世界仅有极少数感染猪链球菌的病例,其中没有一例来自印度。在本病例中,一名老年糖尿病患者出现背痛、头痛和发热,并伴有严重的神经系统恶化,被诊断为严重的侵袭性猪链球菌感染。他患有脑积水,需要进行脑室腹腔分流术。患者接受了长期的氨苄西林和万古霉素静脉注射治疗。
{"title":"A Case of <i>Streptococcus iniae</i> Pyocephalus, Subdural Empyema, and Diffuse Leptomeningitis in an Elderly Male: A Case Report.","authors":"Abdeali Ginwala, Ajit Tambolkar, Sanjay Pujari","doi":"10.59556/japi.72.0689","DOIUrl":"10.59556/japi.72.0689","url":null,"abstract":"<p><p>We present a case of Streptococcus iniae causing leptomeningitis, pyocephalus, and subdural empyema in an elderly male from India. There have been only a handful of cases of S. iniae infection reported worldwide, and none of them have been from India. In this case, an elderly diabetic patient presenting with backache, headache, and fever with severe neurological worsening was diagnosed with severe invasive S. iniae infection. He had hydrocephalus that needed ventriculoperitoneal shunting. The patient was treated with a prolonged course of intravenous ampicillin and vancomycin.</p>","PeriodicalId":22693,"journal":{"name":"The Journal of the Association of Physicians of India","volume":"72 10","pages":"e34-e36"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142401406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Journal of the Association of Physicians of India
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1